BioCentury
ARTICLE | Clinical News

MFG-gamma c gene therapy to treat X-linked severe combined immunodeficiency regulatory update

February 17, 2003 8:00 AM UTC

The French health authority, Afssaps, released a report confirming that aberrant LM0-2 function is the probable cause of T cell lymphoproliferative disease observed in two patients taking part in a F...